SUMO2 Rabbit Polyclonal Antibody

SUMO2 Rabbit Polyclonal Antibody

To Order Contact Us Below:

    SUMO2 Polyclonal Antibody
    ES9018-50ul 50ul
    EUR 248.4
    Description: A Rabbit Polyclonal antibody against SUMO2 from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA

    SUMO2 Rabbit pAb
    A2486-100ul 100 ul
    EUR 369.6

    SUMO2 Rabbit pAb
    A2486-200ul 200 ul
    EUR 550.8

    SUMO2 Rabbit pAb
    A2486-20ul 20 ul
    EUR 219.6

    SUMO2 Rabbit pAb
    A2486-50ul 50 ul
    EUR 267.6

    SUMO2 Rabbit pAb
    A2571-100ul 100 ul
    EUR 369.6

    SUMO2 Rabbit pAb
    A2571-200ul 200 ul
    EUR 550.8

    SUMO2 Rabbit pAb
    A2571-20ul 20 ul
    EUR 219.6

    SUMO2 Rabbit pAb
    A2571-50ul 50 ul
    EUR 267.6

    SUMO2 Rabbit pAb
    A1523-100ul 100 ul
    EUR 369.6

    SUMO2 Rabbit pAb
    A1523-200ul 200 ul
    EUR 550.8

    SUMO2 Rabbit pAb
    A1523-20ul 20 ul
    EUR 219.6

    SUMO2 Rabbit pAb
    A1523-50ul 50 ul
    EUR 267.6

    Polyclonal SUMO2/3 Antibody
    APR06632G 0.1 mg
    EUR 790.8
    Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SUMO2/3 . This antibody is tested and proven to work in the following applications:

    Human Small Ubiquitin Related Modifier Protein 2 (SUMO2) ELISA Kit
    DLR-SUMO2-Hu-48T 48T
    EUR 620.4
    Description: A sandwich quantitative ELISA assay kit for detection of Human Small Ubiquitin Related Modifier Protein 2 (SUMO2) in samples from tissue homogenates, cell lysates or other biological fluids.

    Human Small Ubiquitin Related Modifier Protein 2 (SUMO2) ELISA Kit
    DLR-SUMO2-Hu-96T 96T
    EUR 807.6
    Description: A sandwich quantitative ELISA assay kit for detection of Human Small Ubiquitin Related Modifier Protein 2 (SUMO2) in samples from tissue homogenates, cell lysates or other biological fluids.

    Human Small Ubiquitin Related Modifier Protein 2 (SUMO2) ELISA Kit
    RD-SUMO2-Hu-48Tests 48 Tests
    EUR 625.2

    Human Small Ubiquitin Related Modifier Protein 2 (SUMO2) ELISA Kit
    RD-SUMO2-Hu-96Tests 96 Tests
    EUR 867.6

    Human Small Ubiquitin Related Modifier Protein 2 (SUMO2) ELISA Kit
    RDR-SUMO2-Hu-48Tests 48 Tests
    EUR 652.8

    Human Small Ubiquitin Related Modifier Protein 2 (SUMO2) ELISA Kit
    RDR-SUMO2-Hu-96Tests 96 Tests
    EUR 907.2

    SUMO2/3 (SUMO2/3) Antibody
    20-abx008699
    • EUR 360.00
    • EUR 526.80
    • EUR 226.80
    • 100 ul
    • 200 ul
    • 30 ul

    SUMO2/3 (SUMO2/3) Antibody
    abx026675-400ul 400 ul
    EUR 627.6

    SUMO2/3 (SUMO2/3) Antibody
    abx026675-80l 80 µl
    EUR 343.2

    SUMO2/3 (SUMO2/3) Antibody
    abx026676-400ul 400 ul
    EUR 627.6

    SUMO2/3 (SUMO2/3) Antibody
    abx026676-80l 80 µl
    EUR 343.2

    SUMO2/3 (SUMO2/3) Antibody
    abx026683-400ul 400 ul
    EUR 627.6

    SUMO2/3 (SUMO2/3) Antibody
    abx026683-80l 80 µl
    EUR 343.2

    SUMO2/3 (SUMO2/3) Antibody
    abx238390-100ug 100 ug
    EUR 610.8

    SUMO2/3 (SUMO2/3) Antibody
    abx238391-100ug 100 ug
    EUR 661.2

    SUMO2 antibody
    70R-20650 50 ul
    EUR 522
    Description: Rabbit polyclonal SUMO2 antibody

    SUMO2 antibody
    38405-100ul 100ul
    EUR 302.4

    SUMO2 Antibody
    32722-100ul 100ul
    EUR 302.4

    SUMO2 antibody
    10R-1181 100 ul
    EUR 379.2
    Description: Mouse monoclonal SUMO2 antibody

    SUMO2 Antibody
    ABD7024 100 ug
    EUR 525.6

    SUMO2 Antibody
    1-CSB-PA05009A0Rb
    • EUR 380.40
    • EUR 402.00
    • 100ug
    • 50ug
    Description: A polyclonal antibody against SUMO2. Recognizes SUMO2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200

    SUMO2 Antibody
    DF7024 200ul
    EUR 420

    SUMO2 Antibody
    CSB-PA099258-100ul 100ul
    EUR 379.2
    Description: A polyclonal antibody against SUMO2. Recognizes SUMO2 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:3000, IHC:1:50-1:100

    SUMO2 Antibody
    1-CSB-PA022949GA01HU
    • EUR 716.40
    • EUR 399.60
    • 150ul
    • 50ul
    Description: A polyclonal antibody against SUMO2. Recognizes SUMO2 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC

    SUMO2 Antibody
    F52344-0.08ML 0.08 ml
    EUR 165

    SUMO2 Antibody
    F42016-0.08ML 0.08 ml
    EUR 165

    SUMO2 Antibody
    F42497-0.08ML 0.08 ml
    EUR 165

    SUMO2 Antibody
    F42497-0.4ML 0.4 ml
    EUR 389

    SUMO2 Antibody
    F42523-0.4ML 0.4 ml
    EUR 379

    SUMO2 Antibody
    V2860-100UG 100 ug
    EUR 499
    Description: The small ubiquitin-related modifier (SUMO) proteins, which include SUMO-1, 2 and 3, belong to the ubiquitin-like protein family. Like ubiquitin, the SUMO proteins are synthesized as precursor proteins that undergo processing before conjugation to target proteins. Also, both utilize the E1, E2 and E3 cascade enzymes for conjugation. However, SUMO and ubiquitin differ with respect to targeting. Ubiquitination predominantly targets proteins for degradation, whereas sumoylation targets proteins to a variety of cellular processing, including nuclear transport, transcriptional regulation, apoptosis and protein stability. The unconjugated SUMO-1, 2 and 3 proteins localize to the nuclear membrane, nuclear bodies and cytoplasm, respectively. SUMO-1 utilizes Ubc9 for conjugation to several target proteins, which include MDM2, p53, PML and RanGap1. SUMO-2 and 3 contribute to a greater percentage of protein modification than does SUMO-1 and unlike SUMO-1, they can form polymeric chains. In addition, SUMO-3 regulates beta-Amyloid generation and may be critical in the onset or progression of Alzheimer s disease.

    SUMO2 Antibody
    V2860-20UG 20 ug
    EUR 219
    Description: The small ubiquitin-related modifier (SUMO) proteins, which include SUMO-1, 2 and 3, belong to the ubiquitin-like protein family. Like ubiquitin, the SUMO proteins are synthesized as precursor proteins that undergo processing before conjugation to target proteins. Also, both utilize the E1, E2 and E3 cascade enzymes for conjugation. However, SUMO and ubiquitin differ with respect to targeting. Ubiquitination predominantly targets proteins for degradation, whereas sumoylation targets proteins to a variety of cellular processing, including nuclear transport, transcriptional regulation, apoptosis and protein stability. The unconjugated SUMO-1, 2 and 3 proteins localize to the nuclear membrane, nuclear bodies and cytoplasm, respectively. SUMO-1 utilizes Ubc9 for conjugation to several target proteins, which include MDM2, p53, PML and RanGap1. SUMO-2 and 3 contribute to a greater percentage of protein modification than does SUMO-1 and unlike SUMO-1, they can form polymeric chains. In addition, SUMO-3 regulates beta-Amyloid generation and may be critical in the onset or progression of Alzheimer s disease.

    SUMO2 Antibody
    V2860IHC-7ML 7 ml
    EUR 499
    Description: The small ubiquitin-related modifier (SUMO) proteins, which include SUMO-1, 2 and 3, belong to the ubiquitin-like protein family. Like ubiquitin, the SUMO proteins are synthesized as precursor proteins that undergo processing before conjugation to target proteins. Also, both utilize the E1, E2 and E3 cascade enzymes for conjugation. However, SUMO and ubiquitin differ with respect to targeting. Ubiquitination predominantly targets proteins for degradation, whereas sumoylation targets proteins to a variety of cellular processing, including nuclear transport, transcriptional regulation, apoptosis and protein stability. The unconjugated SUMO-1, 2 and 3 proteins localize to the nuclear membrane, nuclear bodies and cytoplasm, respectively. SUMO-1 utilizes Ubc9 for conjugation to several target proteins, which include MDM2, p53, PML and RanGap1. SUMO-2 and 3 contribute to a greater percentage of protein modification than does SUMO-1 and unlike SUMO-1, they can form polymeric chains. In addition, SUMO-3 regulates beta-Amyloid generation and may be critical in the onset or progression of Alzheimer s disease.

    SUMO2 Antibody
    V2860SAF-100UG 100 ug
    EUR 499
    Description: The small ubiquitin-related modifier (SUMO) proteins, which include SUMO-1, 2 and 3, belong to the ubiquitin-like protein family. Like ubiquitin, the SUMO proteins are synthesized as precursor proteins that undergo processing before conjugation to target proteins. Also, both utilize the E1, E2 and E3 cascade enzymes for conjugation. However, SUMO and ubiquitin differ with respect to targeting. Ubiquitination predominantly targets proteins for degradation, whereas sumoylation targets proteins to a variety of cellular processing, including nuclear transport, transcriptional regulation, apoptosis and protein stability. The unconjugated SUMO-1, 2 and 3 proteins localize to the nuclear membrane, nuclear bodies and cytoplasm, respectively. SUMO-1 utilizes Ubc9 for conjugation to several target proteins, which include MDM2, p53, PML and RanGap1. SUMO-2 and 3 contribute to a greater percentage of protein modification than does SUMO-1 and unlike SUMO-1, they can form polymeric chains. In addition, SUMO-3 regulates beta-Amyloid generation and may be critical in the onset or progression of Alzheimer s disease.

    SUMO2 Antibody
    V2861-100UG 100 ug
    EUR 499
    Description: The small ubiquitin-related modifier (SUMO) proteins, which include SUMO-1, 2 and 3, belong to the ubiquitin-like protein family. Like ubiquitin, the SUMO proteins are synthesized as precursor proteins that undergo processing before conjugation to target proteins. Also, both utilize the E1, E2 and E3 cascade enzymes for conjugation. However, SUMO and ubiquitin differ with respect to targeting. Ubiquitination predominantly targets proteins for degradation, whereas sumoylation targets proteins to a variety of cellular processing, including nuclear transport, transcriptional regulation, apoptosis and protein stability. The unconjugated SUMO1, 2 and 3 proteins localize to the nuclear membrane, nuclear bodies and cytoplasm, respectively. SUMO1 utilizes Ubc9 for conjugation to several target proteins, which include MDM2, p53, PML and RanGap1. SUMO-2 and 3 contribute to a greater percentage of protein modification than does SUMO1 and unlike SUMO1, they can form polymeric chains. In addition, SUMO-3 regulates beta-Amyloid generation and may be critical in the onset or progression of Alzheimer s disease.

    SUMO2 Antibody
    V2861-20UG 20 ug
    EUR 219
    Description: The small ubiquitin-related modifier (SUMO) proteins, which include SUMO-1, 2 and 3, belong to the ubiquitin-like protein family. Like ubiquitin, the SUMO proteins are synthesized as precursor proteins that undergo processing before conjugation to target proteins. Also, both utilize the E1, E2 and E3 cascade enzymes for conjugation. However, SUMO and ubiquitin differ with respect to targeting. Ubiquitination predominantly targets proteins for degradation, whereas sumoylation targets proteins to a variety of cellular processing, including nuclear transport, transcriptional regulation, apoptosis and protein stability. The unconjugated SUMO1, 2 and 3 proteins localize to the nuclear membrane, nuclear bodies and cytoplasm, respectively. SUMO1 utilizes Ubc9 for conjugation to several target proteins, which include MDM2, p53, PML and RanGap1. SUMO-2 and 3 contribute to a greater percentage of protein modification than does SUMO1 and unlike SUMO1, they can form polymeric chains. In addition, SUMO-3 regulates beta-Amyloid generation and may be critical in the onset or progression of Alzheimer s disease.

    SUMO2 Antibody
    V2861IHC-7ML 7 ml
    EUR 499
    Description: The small ubiquitin-related modifier (SUMO) proteins, which include SUMO-1, 2 and 3, belong to the ubiquitin-like protein family. Like ubiquitin, the SUMO proteins are synthesized as precursor proteins that undergo processing before conjugation to target proteins. Also, both utilize the E1, E2 and E3 cascade enzymes for conjugation. However, SUMO and ubiquitin differ with respect to targeting. Ubiquitination predominantly targets proteins for degradation, whereas sumoylation targets proteins to a variety of cellular processing, including nuclear transport, transcriptional regulation, apoptosis and protein stability. The unconjugated SUMO1, 2 and 3 proteins localize to the nuclear membrane, nuclear bodies and cytoplasm, respectively. SUMO1 utilizes Ubc9 for conjugation to several target proteins, which include MDM2, p53, PML and RanGap1. SUMO-2 and 3 contribute to a greater percentage of protein modification than does SUMO1 and unlike SUMO1, they can form polymeric chains. In addition, SUMO-3 regulates beta-Amyloid generation and may be critical in the onset or progression of Alzheimer s disease.

    SUMO2 Antibody
    V2861SAF-100UG 100 ug
    EUR 499
    Description: The small ubiquitin-related modifier (SUMO) proteins, which include SUMO-1, 2 and 3, belong to the ubiquitin-like protein family. Like ubiquitin, the SUMO proteins are synthesized as precursor proteins that undergo processing before conjugation to target proteins. Also, both utilize the E1, E2 and E3 cascade enzymes for conjugation. However, SUMO and ubiquitin differ with respect to targeting. Ubiquitination predominantly targets proteins for degradation, whereas sumoylation targets proteins to a variety of cellular processing, including nuclear transport, transcriptional regulation, apoptosis and protein stability. The unconjugated SUMO1, 2 and 3 proteins localize to the nuclear membrane, nuclear bodies and cytoplasm, respectively. SUMO1 utilizes Ubc9 for conjugation to several target proteins, which include MDM2, p53, PML and RanGap1. SUMO-2 and 3 contribute to a greater percentage of protein modification than does SUMO1 and unlike SUMO1, they can form polymeric chains. In addition, SUMO-3 regulates beta-Amyloid generation and may be critical in the onset or progression of Alzheimer s disease.

    SUMO2 Antibody
    V7051-100UG 100 ug
    EUR 499
    Description: The small ubiquitin-related modifier (SUMO) proteins, which include SUMO-1, 2 and 3, belong to the ubiquitin-like protein family. Like ubiquitin, the SUMO proteins are synthesized as precursor proteins that undergo processing before conjugation to target proteins. Sumoylation targets proteins to a variety of cellular processing, including nuclear transport, transcriptional regulation, apoptosis and protein stability. The unconjugated SUMO-1, 2 and 3 proteins localize to the nuclear membrane, nuclear bodies and cytoplasm, respectively. SUMO-2 and 3 contribute to a greater percentage of protein modification than does SUMO-1 and unlike SUMO-1, they can form polymeric chains.

    SUMO2 Antibody
    V7051-20UG 20 ug
    EUR 219
    Description: The small ubiquitin-related modifier (SUMO) proteins, which include SUMO-1, 2 and 3, belong to the ubiquitin-like protein family. Like ubiquitin, the SUMO proteins are synthesized as precursor proteins that undergo processing before conjugation to target proteins. Sumoylation targets proteins to a variety of cellular processing, including nuclear transport, transcriptional regulation, apoptosis and protein stability. The unconjugated SUMO-1, 2 and 3 proteins localize to the nuclear membrane, nuclear bodies and cytoplasm, respectively. SUMO-2 and 3 contribute to a greater percentage of protein modification than does SUMO-1 and unlike SUMO-1, they can form polymeric chains.

    SUMO2 Antibody
    V7051IHC-7ML 7 ml
    EUR 499
    Description: The small ubiquitin-related modifier (SUMO) proteins, which include SUMO-1, 2 and 3, belong to the ubiquitin-like protein family. Like ubiquitin, the SUMO proteins are synthesized as precursor proteins that undergo processing before conjugation to target proteins. Sumoylation targets proteins to a variety of cellular processing, including nuclear transport, transcriptional regulation, apoptosis and protein stability. The unconjugated SUMO-1, 2 and 3 proteins localize to the nuclear membrane, nuclear bodies and cytoplasm, respectively. SUMO-2 and 3 contribute to a greater percentage of protein modification than does SUMO-1 and unlike SUMO-1, they can form polymeric chains.

    SUMO2 Antibody
    V7051SAF-100UG 100 ug
    EUR 499
    Description: The small ubiquitin-related modifier (SUMO) proteins, which include SUMO-1, 2 and 3, belong to the ubiquitin-like protein family. Like ubiquitin, the SUMO proteins are synthesized as precursor proteins that undergo processing before conjugation to target proteins. Sumoylation targets proteins to a variety of cellular processing, including nuclear transport, transcriptional regulation, apoptosis and protein stability. The unconjugated SUMO-1, 2 and 3 proteins localize to the nuclear membrane, nuclear bodies and cytoplasm, respectively. SUMO-2 and 3 contribute to a greater percentage of protein modification than does SUMO-1 and unlike SUMO-1, they can form polymeric chains.

    SUMO2 Antibody
    CSB-PA099258- each
    EUR 402
    Description: A polyclonal antibody against SUMO2. Recognizes SUMO2 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:3000, IHC:1:50-1:100

    Polyclonal SUMO2 Antibody (aa44-93)
    APR03220G 0.05ml
    EUR 580.8
    Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SUMO2 (aa44-93). This antibody is tested and proven to work in the following applications:

    Polyclonal SUMO2 Antibody (C-term)
    APR03744G 0.1ml
    EUR 580.8
    Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SUMO2 (C-term). This antibody is tested and proven to work in the following applications:

    Anti-Sumo2/3 Rabbit Monoclonal Antibody
    M01282-2 100ug/vial
    EUR 476.4
    Description: Rabbit Monoclonal Sumo2/3 Antibody. Validated in IF, WB and tested in Human, Mouse, Rat.

    SUMO2
    E541-030 100ug
    EUR 411.6

    Polyclonal SUMO2/3 Antibody (N-term)
    APR03665G 0.1ml
    EUR 580.8
    Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SUMO2/3 (N-term). This antibody is tested and proven to work in the following applications:

    Polyclonal SUMO2/3 Antibody (C-term)
    APR03666G 0.1ml
    EUR 580.8
    Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human SUMO2/3 (C-term). This antibody is tested and proven to work in the following applications:

    SUMO2/3 Antibody
    5755-002mg 0.02 mg
    EUR 206.18
    Description: SUMO2/3 Antibody: Small ubiquitin-like modifiers (SUMOs) are a family of small, related proteins (Sumo-1/2/3/4) that can be enzymatically attached to a target protein by a post-translational modification process termed sumoylation, which is a major regulator of protein function in cellular processes such as nuclear transport, transcriptional regulation, apoptosis and protein stability. All SUMO proteins localize to the nucleus and are covalently conjugated, affecting protein structure, function and interactions. SUMO2 and 3 are 96% identical and are more mobile within nucleus relative to SUMO1. Specific functional differences between SUMO1 and SUMO2 and 3 remain to be identified.

    SUMO2/3 Antibody
    5755-01mg 0.1 mg
    EUR 523.7
    Description: SUMO2/3 Antibody: Small ubiquitin-like modifiers (SUMOs) are a family of small, related proteins (Sumo-1/2/3/4) that can be enzymatically attached to a target protein by a post-translational modification process termed sumoylation, which is a major regulator of protein function in cellular processes such as nuclear transport, transcriptional regulation, apoptosis and protein stability. All SUMO proteins localize to the nucleus and are covalently conjugated, affecting protein structure, function and interactions. SUMO2 and 3 are 96% identical and are more mobile within nucleus relative to SUMO1. Specific functional differences between SUMO1 and SUMO2 and 3 remain to be identified.

    SUMO2/3 antibody
    70R-50404 100 ul
    EUR 292.8
    Description: Purified Polyclonal SUMO2/3 antibody

    SUMO2/3 antibody
    70R-30820 100 ug
    EUR 392.4
    Description: Rabbit polyclonal SUMO2/3 antibody

    SUMO2/3 antibody
    70R-30839 100 ug
    EUR 392.4
    Description: Rabbit polyclonal SUMO2/3 antibody

    Human SUMO2 Antibody
    32621-05111 150 ug
    EUR 313.2

    SUMO2/3 Antibody
    25117-100ul 100ul
    EUR 468

    Xenopus SUMO2 Antibody
    abx027062-400ul 400 ul
    EUR 627.6

    Xenopus SUMO2 Antibody
    abx027062-80l 80 µl
    EUR 343.2

    SUMO2 Conjugated Antibody
    C32722 100ul
    EUR 476.4

    Anti-SUMO2 antibody
    STJ116151 100 µl
    EUR 332.4
    Description: This gene encodes a protein that is a member of the SUMO (small ubiquitin-like modifier) protein family. It functions in a manner similar to ubiquitin in that it is bound to target proteins as part of a post-translational modification system. However, unlike ubiquitin which targets proteins for degradation, this protein is involved in a variety of cellular processes, such as nuclear transport, transcriptional regulation, apoptosis, and protein stability. It is not active until the last two amino acids of the carboxy-terminus have been cleaved off. Numerous pseudogenes have been reported for this gene. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.

    Anti-SUMO2 antibody
    STJ25749 100 µl
    EUR 332.4
    Description: This gene encodes a protein that is a member of the SUMO (small ubiquitin-like modifier) protein family. It functions in a manner similar to ubiquitin in that it is bound to target proteins as part of a post-translational modification system. However, unlike ubiquitin which targets proteins for degradation, this protein is involved in a variety of cellular processes, such as nuclear transport, transcriptional regulation, apoptosis, and protein stability. It is not active until the last two amino acids of the carboxy-terminus have been cleaved off. Numerous pseudogenes have been reported for this gene. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.

    Anti-SUMO2 antibody
    STJ28142 100 µl
    EUR 332.4
    Description: This gene encodes a protein that is a member of the SUMO (small ubiquitin-like modifier) protein family. It functions in a manner similar to ubiquitin in that it is bound to target proteins as part of a post-translational modification system. However, unlike ubiquitin which targets proteins for degradation, this protein is involved in a variety of cellular processes, such as nuclear transport, transcriptional regulation, apoptosis, and protein stability. It is not active until the last two amino acids of the carboxy-terminus have been cleaved off. Numerous pseudogenes have been reported for this gene. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.

    Anti-SUMO2 antibody
    STJ190176 200 µl
    EUR 236.4
    Description: Unconjugated Rabbit polyclonal to SUMO2

    SUMO2/3 Antibody
    F42018-0.08ML 0.08 ml
    EUR 165

    SUMO2/3 Antibody
    F42018-0.4ML 0.4 ml
    EUR 379

    SUMO2/3 Antibody
    F42027-0.08ML 0.08 ml
    EUR 165

    SUMO2/3 Antibody
    F42027-0.4ML 0.4 ml
    EUR 389

    SUMO2 Antibody (Xenopus)
    F42523-0.08ML 0.08 ml
    EUR 165

    SUMO2/3 Antibody
    F42562-0.08ML 0.08 ml
    EUR 165

    SUMO2/3 Antibody
    F42562-0.4ML 0.4 ml
    EUR 389

    SUMO2/3 Antibody
    V9080-100UG 100 ug
    EUR 499
    Description: This mAb reacts with both SUMO-2 and SUMO-3. The small ubiquitin-related modifier (SUMO) proteins, which include SUMO-1, 2 and 3, belong to the ubiquitin-like protein family. Like ubiquitin, the SUMO proteins are synthesized as precursor proteins that undergo processing before conjugation to target proteins. Also, both utilize the E1, E2 and E3 cascade enzymes for conjugation. However, SUMO and ubiquitin differ with respect to targeting. Ubiquitination predominantly targets proteins for degradation, whereas sumoylation targets proteins to a variety of cellular processing, including nuclear transport, transcriptional regulation, apoptosis and protein stability. The unconjugated SUMO-1, 2 and 3 proteins localize to the nuclear membrane, nuclear bodies and cytoplasm, respectively. SUMO-1 utilizes Ubc9 for conjugation to several target proteins, which include MDM2, p53, PML and RanGap1. SUMO-2 and 3 contribute to a greater percentage of protein modification than does SUMO-1 and unlike SUMO-1, they can form polymeric chains. In addition, SUMO-3 regulates beta-Amyloid generation and may be critical in the onset or progression of Alzheimer s disease.

    SUMO2/3 Antibody
    V9080-20UG 20 ug
    EUR 219
    Description: This mAb reacts with both SUMO-2 and SUMO-3. The small ubiquitin-related modifier (SUMO) proteins, which include SUMO-1, 2 and 3, belong to the ubiquitin-like protein family. Like ubiquitin, the SUMO proteins are synthesized as precursor proteins that undergo processing before conjugation to target proteins. Also, both utilize the E1, E2 and E3 cascade enzymes for conjugation. However, SUMO and ubiquitin differ with respect to targeting. Ubiquitination predominantly targets proteins for degradation, whereas sumoylation targets proteins to a variety of cellular processing, including nuclear transport, transcriptional regulation, apoptosis and protein stability. The unconjugated SUMO-1, 2 and 3 proteins localize to the nuclear membrane, nuclear bodies and cytoplasm, respectively. SUMO-1 utilizes Ubc9 for conjugation to several target proteins, which include MDM2, p53, PML and RanGap1. SUMO-2 and 3 contribute to a greater percentage of protein modification than does SUMO-1 and unlike SUMO-1, they can form polymeric chains. In addition, SUMO-3 regulates beta-Amyloid generation and may be critical in the onset or progression of Alzheimer s disease.

    SUMO2/3 Antibody
    V9080IHC-7ML 7 ml
    EUR 499
    Description: This mAb reacts with both SUMO-2 and SUMO-3. The small ubiquitin-related modifier (SUMO) proteins, which include SUMO-1, 2 and 3, belong to the ubiquitin-like protein family. Like ubiquitin, the SUMO proteins are synthesized as precursor proteins that undergo processing before conjugation to target proteins. Also, both utilize the E1, E2 and E3 cascade enzymes for conjugation. However, SUMO and ubiquitin differ with respect to targeting. Ubiquitination predominantly targets proteins for degradation, whereas sumoylation targets proteins to a variety of cellular processing, including nuclear transport, transcriptional regulation, apoptosis and protein stability. The unconjugated SUMO-1, 2 and 3 proteins localize to the nuclear membrane, nuclear bodies and cytoplasm, respectively. SUMO-1 utilizes Ubc9 for conjugation to several target proteins, which include MDM2, p53, PML and RanGap1. SUMO-2 and 3 contribute to a greater percentage of protein modification than does SUMO-1 and unlike SUMO-1, they can form polymeric chains. In addition, SUMO-3 regulates beta-Amyloid generation and may be critical in the onset or progression of Alzheimer s disease.

    SUMO2/3 Antibody
    V9080SAF-100UG 100 ug
    EUR 499
    Description: This mAb reacts with both SUMO-2 and SUMO-3. The small ubiquitin-related modifier (SUMO) proteins, which include SUMO-1, 2 and 3, belong to the ubiquitin-like protein family. Like ubiquitin, the SUMO proteins are synthesized as precursor proteins that undergo processing before conjugation to target proteins. Also, both utilize the E1, E2 and E3 cascade enzymes for conjugation. However, SUMO and ubiquitin differ with respect to targeting. Ubiquitination predominantly targets proteins for degradation, whereas sumoylation targets proteins to a variety of cellular processing, including nuclear transport, transcriptional regulation, apoptosis and protein stability. The unconjugated SUMO-1, 2 and 3 proteins localize to the nuclear membrane, nuclear bodies and cytoplasm, respectively. SUMO-1 utilizes Ubc9 for conjugation to several target proteins, which include MDM2, p53, PML and RanGap1. SUMO-2 and 3 contribute to a greater percentage of protein modification than does SUMO-1 and unlike SUMO-1, they can form polymeric chains. In addition, SUMO-3 regulates beta-Amyloid generation and may be critical in the onset or progression of Alzheimer s disease.

    SUMO2/3 Antibody
    V7091-100UG 100 ug
    EUR 499
    Description: The small ubiquitin-related modifier (SUMO) proteins, which include SUMO1, 2 and 3, belong to the ubiquitin-like protein family. SUMO proteins are synthesized as precursors that undergo processing before conjugation to target proteins. Sumoylation targets for a variety of cellular processing, including nuclear transport, transcriptional regulation, apoptosis and protein stability. SUMO2/3 contribute to a greater percentage of protein modification than does SUMO1 and they can form polymeric chains. In addition, SUMO3 regulates beta-Amyloid generation and may be critical in the onset or progression of Alzheimer�s disease.

    SUMO2 Rabbit Polyclonal Antibody

    Scroll to Top